Isolated microorganisms from febrile neutropenic patients and their antimicrobial susceptibility: A data of 2005;Febril nötropenik hastalardan i̇zole edilen mikroorganizmalar ve antimikrobiyal duyarliliklari: 2005 Yili verileri

Erciyes Tip Dergisi

Volumn 29, Issue 5, 2007, Pages 376-380

  Demiraslan, Hayati ^a   Yildiz, Orhan ^a   Kaynar, Leylagül ^a   Altuntaş, Fevzi ^a   Eser, Bülent ^a   Aygen, Bilgehan ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Anti bacterial agents; Bacterial infection; Febrile neutropenia; Susceptibility

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM; BLOOD; COAGULASE NEGATIVE STAPHYLOCOCCUS; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HUMAN; KLEBSIELLA; NONHUMAN; SPUTUM; URINE; WOUND;

EID: 42149131592     PISSN: 1300199X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hughes WT, Armstrong D, Bodey GP. et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. CID 2002; 34: 730-51.
2. Çaǧatay AA, Punar M, Nalçaci M, arkadaşlari. Hematolojik malignitesi olan hastalarda febril nötropeni etkenleri. Klimik Dergisi 2001;14(1):7-9.
3. Glauser M. Empiric therapy of bacterial infections in patients with severe neutropenia. Diagn Microbiol Infec Dis 1998; 31:467-72.
4. Ortega M, Rovira M, Almela M, et al. Bacterial and fungal bloodstream isolates from 796 hemapoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005; 84: 40-47.
5. Arikan Akan Ö. Microorganisms isolated from blood cultures of febrile neutropenic patients in İbn-i Sina Hospital. Turk J Haematol 2003; 20; 227-31.
6. Winfred VK, Elena A, Margret O, et al. Emergence of fluoroquinolone- resistant Escherichia coli at a cancer center. Antimicrobiol Agents and Chemother 1994:38:681-687.
7. Pascoe J and Cullen M. The prevention of febrile neutropenia. Current Opinion in Oncology 2006; 18: 325-29.
8. Rolston KVI. Challenge in the treatment of infections caused by gram-pozitive anagram- negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005; 40:S246-52.
9. Bradford PA. Extended-spectrum â-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiol Rev 2001; 14: 933-51.4
10. Febril nötropenik hastalarda tarn ve tedavi kilavuzu. Febril Nötropeni Çalişma Grubu. Flora 2004;9:5-28.
11. Toleman MA, Rolston K, Jones KN, et al. blaVIM-7. an evolutionarily distinct metallo-â-lactamase gene in a Pseudomonas aeruginosa isolate from the United Slates. Antimicrobiol Agents and Chemother 2004; 48: 329-32.